InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: MedResCollab post# 200932

Wednesday, 07/10/2019 6:02:33 PM

Wednesday, July 10, 2019 6:02:33 PM

Post# of 424128
M-

Why anyone would want to sit passively in a long position here is beyond us. Especially after this run up. All you are possibly missing by selling until early-mid September are negative catalysts. In fact, the only positions that make sense until then are short leveraged

A few reason:
(i) no Adcom communication (or lack of any info re. AdCom) in the mid-cycle communication … "due" by 7/12
(ii) ICER draft report (7/24) support the use of Vascepa
(iii) earlier approval by the FDA

(i) and (ii) have a high probability … the (iii) could happen (by any day after August 1).

Best,
G

"There are some things money can't buy. For everything else, there's AMRN."

Disclosure: I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News